Fatal ergotism induced by an HIV protease inhibitor.
Tribble
Marc A
MA
Gregg
Clark R
CR
Margolis
David M
DM
Amirkhan
Robin
R
Smith
James W
JW
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D002110:Caffeine / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D004347:Drug Interactions; D004878:Ergotamine / Q000009:adverse effects* / Q000627:therapeutic use; D004881:Ergotism / Q000209:etiology*; D017809:Fatal Outcome; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006261:Headache / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000139:chemically induced; D008297:Male; D008875:Middle Aged
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; C037330:caffeine, ergotamine drug combination; D002110:Caffeine; D004878:Ergotamine